Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 313 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal Cancer				Phase II				01023018 NCT00569790
	Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC)				Phase II				01023019 NCT00569699
	Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer				Phase II				01023020 NCT00569335
	Concentration of Ertapenem in Colorectal Tissue				Phase IV				01-07 NCT00535652
	Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal Cancer				Phase II				022-03 XEL308, NCT00459901
	Allogeneic Whole Cell Cancer Vaccine for Metastatic Epithelial Tumors				Phase II, Phase I				0359-08-HMO-CTIL NCT00722228
	Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases				Phase II				04-061 NCT00587964
	A Study of Picoplatin in Colorectal Cancer				Phase I				0501 NCT00478946
	Alpha-Type-1 Dendritic Cell-Based Vaccines in Patients With Metastatic Colorectal Cancer				Phase I				05-063 NCT00558051
	Safety Study of Oxaliplatin and 5-Fluorouracil Followed by FUDR for Unresectable Colorectal Liver Metastases				Phase I				05-096 NCT00557557


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute